Bradley L Campbell Amicus Therapeutics, Inc. (FOLD) insider trading activity

Bradley L Campbell is President and CEO of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 886,654 shares of FOLD, which is worth approximately $8.66 Million. The most recent transaction as insider was on Dec 02, 2024, when has been sold 7,500 shares (Common Stock) at a price of $10.02 per share, resulting in proceeds of $75,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 887K

0% 3M change

9.54% 12M change

Total Value Held $8.66 Million

Bradley L Campbell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	SELL Open market or private sale	$75,150 $10.02 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Nov 06 2024	SELL Open market or private sale	$98,762 $12.5 p/Share	7,901 Reduced 0.88%	886,654 Common Stock
Nov 06 2024	BUY Exercise of conversion of derivative security	$97,024 $12.28 p/Share	7,901 Added 0.88%	894,555 Common Stock
Nov 01 2024	SELL Open market or private sale	$85,950 $11.46 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Oct 01 2024	SELL Open market or private sale	$79,500 $10.6 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Sep 03 2024	SELL Open market or private sale	$87,825 $11.71 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Aug 01 2024	SELL Open market or private sale	$77,550 $10.34 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Jul 05 2024	SELL Open market or private sale	$61,000 $10.0 p/Share	6,100 Reduced 0.68%	886,654 Common Stock
Jul 05 2024	BUY Exercise of conversion of derivative security	$52,521 $8.61 p/Share	6,100 Added 0.68%	892,754 Common Stock
Jul 01 2024	SELL Open market or private sale	$14,000 $10.0 p/Share	1,400 Reduced 0.16%	886,654 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$12,054 $8.61 p/Share	1,400 Added 0.16%	888,054 Common Stock
Jun 03 2024	SELL Open market or private sale	$75,000 $10.0 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
May 01 2024	SELL Open market or private sale	$75,525 $10.07 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Apr 01 2024	SELL Open market or private sale	$87,525 $11.67 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$153,545 $11.48 p/Share	13,375 Reduced 1.49%	886,654 Common Stock
Mar 01 2024	SELL Open market or private sale	$208,045 $13.14 p/Share	15,833 Reduced 1.78%	871,219 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$165,454 $10.45 p/Share	15,833 Added 1.75%	887,052 Common Stock

BLC

Bradley L Campbell

President and CEO

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account